% | $
Quotes you view appear here for quick access.

VPHM Message Board

  • oinchats oinchats Nov 16, 2013 11:36 PM Flag

    Here's a shocker

    Goldman Sachs was hired by Viro on or about Sept 16, 2013 to explore the possibility of a sale to other potential suitors. Goldman Sachs increased their holdings of Viro 3Q over 99% by purchasing 832,185 new shares. Hmm

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • they did a bad job of representing VaPHoooM!... Biotech market multiple for ones with a single product is around 8-15X revenue... the ones that deals with rarer diseases get richer multiple... we are bought around that regular multiple... just revenue... no premium given to the pipeline and the fact that VaPHoooM! has more than one product...
      I think they were heavy on the short side... they must also deliver shares for the call options that VaPHoooM! purchased from them...
      the lawyers should check on all these... how GS was not the right representative on the deal... they've got too much conflict of interest... The BOD got hoodwinked... imo!
      aloha, K